Abstract
Inhibitory natural killer (NK) cell receptors recognize MHC class I (MHC-I) in trans on target cells and suppress cytotoxicity. Some NK cell receptors recognize MHC-I in cis, but the role of this interaction is uncertain. Ly49Q, an atypical Ly49 receptor expressed in non-NK cells, binds MHC-I in cis and mediates chemotaxis of neutrophils and type I interferon production by plasmacytoid dendritic cells. We identified a lipid-binding motif in the juxtamembrane region of Ly49Q and found that Ly49Q organized functional membrane domains comprising sphingolipids via sulfatide binding. Ly49Q recruited actin-remodeling molecules to an immunoreceptor tyrosine-based inhibitory motif, which enabled the sphingolipid-enriched membrane domain to mediate complicated actin remodeling at the lamellipodia and phagosome membranes during phagocytosis. Thus, Ly49Q facilitates integrative regulation of proteins and lipid species to construct a cell type-specific membrane platform. Other Ly49 members possess lipid binding motifs; therefore, membrane platform organization may be a primary role of some NK cell receptors.
Keywords: inhibitory receptor, Ly49, MHC class I, cis interaction, sphingolipids, 2 phagocytosis, lipid raft, macrophage
Introduction
Natural killer (NK) cells become tolerant to healthy self cells by sensing the presence of self MHC class I (MHC-I) (1, 2). In self and nonself discrimination, MHC-I interacts with its receptors in trans; that is, receptors bind to ligands expressed on other cells. In addition, a number of receptors interact with MHC-I expressed on the same cell, i.e. a cis interaction (3), which seems to be not involved in self and nonself discrimination. Some cis-interacting receptors have immune regulatory functions (4), but their roles remain largely unknown.
A type II membrane spanning receptor bearing an immunoreceptor tyrosine-based inhibitory motif (ITIM), Ly49Q, is a member of the NK cell receptor family (5–7). However, this receptor is expressed not on NK cells but rather on plasmacytoid dendritic cells (pDCs), neutrophils, and macrophages (Mϕs) (7). Similar to other NK cell receptors, Ly49Q recognizes MHC-I molecules, and the association between Ly49Q and MHC-I occurs in a cis configuration (8). We previously demonstrated that this molecule is critical for type I interferon (IFN-I) production by pDCs (9–12) and for the polarization and chemotaxis of neutrophils (13). Ly49Q colocalizes with the ganglioside GM1 and contributes to lipid raft endocytosis and endolysosomal trafficking (13). Furthermore, Ly49Q plays a unique role as a switch device to induce tonic responses in innate immune cells; that is, Ly49Q functions as an inhibitory receptor in the steady state, but once cells receive inflammatory stimuli, it behaves like an activation receptor by controlling Src family kinases (SFK) and PI3K activation (13).
Mϕs are professional scavengers and can efficiently engulf relatively large particulate materials, such as microbes and apoptotic cells (14, 15). Phagocytosis, which is defined by the ability to engulf particulates exceeding 0.5 µm in diameter, is mediated by phagocytic receptors (15). A broad spectrum of phagocytic receptors, including Fcγ receptors (FcγRs) and lectins, have been identified, and their phagocytic mechanisms have been investigated. Although phagocytic receptors show structural variations and differentially activate membrane-proximal signaling molecules, the common events in phagocytosis are actin remodeling and endocytosis (16). Actin remodeling during phagocytosis is a complex and sequentially regulated process that is a continuation of pseudopod formation. Pseudopods probe for and envelop prey, and the nascent phagocytic vacuole undergoes maturation in which the strict regulation of periphagosomal actin is important. Mϕs can engulf particles over 20 µm in diameter despite their own diameter being approximately 14 µm in size (17). The dynamic change in membrane capacity in focal exocytosis events is concurrently processed with actin remodeling during phagocytosis (18). Therefore, it is important to understand how lipid environments and membrane behaviors are coordinately regulated by actin remodeling in phagocytosis.
The signaling events during FcγR-mediated phagocytosis that lead to plasma membrane pseudopod extension and particle engulfment have been largely elucidated, and the critical roles of Rho GTPases, such as Rac1/2, Cdc42 and RhoA, in shaping and regulating the dynamics of F-actin have been established (16). Strict regulation of phosphoinositide species by phosphoinositide (PI) kinases and their phosphatases, such as Src homology 2 (SH2) domain containing inositol polyphosphate 5-phosphatase 1 (SHIP1) and SHIP2, are at the core of actin regulation (19, 20). In addition to these mechanisms, cholesterol in the plasma membrane is essential for phagocytosis because cholesterol depletion by methyl-β-cyclodextrin (mβCD) severely diminishes phagocytosis (21). Although cholesterol depletion is a harsh treatment, it is believed that membrane lipid microdomains, often referred to as lipid rafts, are needed for phagocytosis. However, a comprehensive understanding of membrane proteins, such as phagocyte receptors, and their interaction with peripheral membrane lipids, including their contribution to lipid rafts, is lacking.
Lipid rafts are defined as cholesterol- and sphingolipid-rich membrane domains and are considered to be important signaling platforms (22–24). Cholesterol and sphingolipids possess saturated fatty acyl chains and organize into tightly packed, liquid-ordered membrane microdomains (25). Various cell surface receptors and intracellular signaling molecules, such as glycosylphosphatidylinositol (GPI)-anchored proteins, Src family kinases (SFK) and small GTPases, are associated with lipid rafts, and such raft-associated proteins are frequently modified with lipid moieties to markedly increase their hydrophobicity (22, 23, 25). Although the significance of partitioning proteins and lipids into a specialized membrane domain is generally accepted, there has been much debate concerning the definition, size, and experimental adequacy of lipid rafts (26). There are several outstanding questions in the field of rafts and functional lipid microdomains. For example, what is the mechanism that regulates raft formation, how are raft properties determined, how is the movement and trafficking of raft domains regulated, and how does the regulation of raft assembly and movement contribute to cellular responses? Elegant studies using liposomes have shown the self-assembly of cholesterols and sphingolipids to form liquid-ordered domains (27–29). These observations strongly indicate that, in cell membranes, including plasma and organelle membranes, membrane domains are arranged to some extent depending on the lipid environment.
In the present study, we identified the cholesterol recognition/interaction amino acid consensus sequence (CRAC) motifs (30, 31) at lipid membrane boundary regions of Ly49Q and other Ly49 molecules and demonstrated the Ly49Q association with sulfatide via its CRAC motif. Our findings revealed a collaborative function between a previously known ITIM and a newly identified CRAC motif of Ly49Q in phagocytosis, which may be helpful in considering the role of cis-interactions of other NK cell receptors expressed on NK cells.
Results
Ly49Q is necessary for FcγR-mediated phagocytosis in Mϕs
We examined the role of Ly49Q (encoded by Klra17 gene) in FcγR-mediated phagocytosis. Klra17-/- peritoneal Mϕs (PEMϕs) ingested fewer beads than Klra17+/+ PEMϕs ( Figure 1A ). Klra17+/+ PEMϕs formed large, directional membrane protrusions promptly after bead binding ( Figure 1B ). Conversely, Klra17-/- PEMϕs did not exhibit membrane ruffling, although F-actin colocalized with beads ( Figure 1B ). Similarly, impaired membrane ruffling was also observed in Klra17-/- PEMϕs by phorbol ester stimulation, which mimics the activation of PKC downstream of FcγR ( Supplementary Figures 1A, B, Supplementary Movies 1 , 2 ). These results indicated that Ly49Q increases FcγR-mediated phagocytosis, possibly by mediating the formation of ruffled membranes.
After incubation for 60 min, the accumulation of MHC-I around phagosomes was observed in both Klra17+/+ and Klra17-/- PEMϕs, although it was less efficient in Klra17-/- PEMϕs than in Klra17+/+ ones ( Figure 1C ). β2 integrins, which are needed for optimal phagocytosis (32), were recruited to bead-containing phagosomes in Klra17+/+ PEMϕs, but β2 integrins in Klra17-/- PEMϕs localized to different regions from bead-containing phagosomes ( Figure 1D ). These results indicated that Ly49Q affected not only phagocytosis efficiency but also phagosome membrane properties by recruiting membrane proteins like MHC-I and β2 integrins.
Ly49Q-dependent properties of phagocytes are important for protection against Salmonellae
We next confirmed the significance of Ly49Q in pathogen engulfment. Salmonella enterica serovar Typhimurium SH100 (S. typhi WT) is a Gram-negative bacterium that infects host cells using the type III secretion system (T3SS) (33). To distinguish phagocytosis from infection, we used the virulence-defective strain S. typhimurium ΔinvA (S. typhi ΔinvA), which is an invasion-defective strain and is thus ingested by phagocytosis (34). Bacterial attachment (after 10 min incubation) did not differ markedly between S. typhi WT and S. typhi ΔinvA strains or between Klra17+/+ and Klra17-/- PEMϕs ( Figure 1E ). Phagocytosis of the opsonized S. typhi ΔinvA strain was decreased in Klra17-/- PEMϕs compared with Klra17+/+ PEMϕ,s, although T3SS-mediated infection of S. typhi WT strains did not markedly differ between Klra17+/+ and Klra17-/- PEMϕs ( Figure 1E ). Unexpectedly, the bactericidicity of Klra17-/- PEMϕ against virulent S. typhi WT was significantly decreased ( Figure 1F ). Activation of ERK and NF-κB by S. typhi WT infection was impaired in Klra17-/- PEMϕs ( Supplementary Figure 1C ) (35, 36); consequently, IL6 production was diminished in Klra17-/- PEMϕs ( Supplementary Figure 1D ). An electron microscopic analysis revealed that although both Klra17+/+ and Klra17-/- PEMϕs showed Salmonella-containing vesicles (SCVs), those in Klra17-/- PEMϕs contained multiple Salmonella particles ( Figure 1G ) (37), possibly due to reduced bactericidal activity. In vivo infection experiments demonstrated that Klra17-/- mice showed augmented splenomegaly and increased titers of S. typhi in the spleen ( Figures 1H, I ). These results indicated that Ly49Q plays a role not only in the phagocytosis of opsonized bacteria but also in the bactericidal activity both in vitro and in vivo.
The Ly49Q ITIM mediates membrane ruffling in the phagocytic region
We next examined the role of Ly49Q ITIM in phagocytosis using PEMϕs obtained from ITIM-less Ly49Q (Ly49Q-YF) transgenic Klra17-/- mice. The number of 2-µm-diameter ingested beads was not significantly affected by the presence or absence of an ITIM ( Supplementary Figures 2A, B ). The number of 6-µm-diameter ingested beads was reduced in the Ly49Q-YF PEMϕs compared with the Ly49Q-WT PEMϕs ( Figure 2A ). However, the degree of reduced phagocytosis caused by ITIM deficiency is less than that caused by Ly49Q deficiency ( Figure 1A ), indicating that ITIM contributes to the efficiency of FcγR-mediated phagocytosis but is not indispensable for this type of phagocytosis. However, we found that the ITIM of Ly49Q was important for actin remodeling in membrane regions where phagocytosis occurs. Ly49Q-WT PEMϕs showed membrane ruffles wrapping around multiple beads ( Figure 2B ). In contrast, in Ly49Q-YF PEMsϕ, beads were captured on cup-like F-actin structures without membrane ruffling ( Figure 2B ). These results indicated that the Ly49Q ITIM is needed for actin remodeling to make membrane ruffles at the site of phagocytosis. Ly49Q-WT proteins were detected around beads and membrane ruffles, but Ly49Q-YF was predominantly located in intracellular vesicular compartments, although it was weakly detected in the region of bead attachment ( Figure 2C ), indicating that the distribution of Ly49Q is regulated in an ITIM-dependent manner. Furthermore, ITIM was needed for the recruitment of MHC-I and β2 integrin at phagosomes ( Figures 2D, E ). Collectively, these results indicated that the ITIM of Ly49Q modifies the mode of phagocytosis of Mϕs by forming ruffled membranes and mobilizing integrins to phagosomes.
The Ly49Q ITIM controls actin remodeling in phagosomes
Since ruffled and nonruffled membranes are sources that provide phagosomes with lipid membranes with different lipid components and proteins (16, 38, 39), we hypothesized that Ly49Q ITIM might affect phagosome properties. Immunohistochemical analyses revealed that, in Ly49Q-YF PEMϕs, phagosomes containing ingested beads were individually surrounded by polymerized actin, while in Ly49Q-WT PEMsϕ, multiple beads were surrounded together by F-actin ( Figure 2F ), resembling macropinocytosis (39). These results suggested that Ly49Q modulates actin remodeling not only during phagocytosis but also in subsequent phagosome formation in an ITIM-dependent manner.
Actin polymerization around a nascent phagosome is transient, and only immature phagosomes possess an actin coat assembly, which greatly influences phagosome maturation by contributing to vesicle docking, fusion, and trafficking (40–42). Therefore, altered properties of phagosomes ( Figures 1C, D ) and SCV ( Figure 1G ) in Klra17-/- PEMϕs may be associated with differences in the particle uptake manner, including actin remodeling.
MHC-I is also needed for membrane ruffle formation and actin remodeling in phagocytosis
We next examined whether or not the binding partner of Ly49Q, MHC-I, contributes to Mϕ phagocytosis. PEMϕs obtained from β2-microglobulin deficient (B2m -/-) mice, in which MHC-I expression is greatly decreased (43), engulfed IgG-opsonized beads, and there was no significant difference in the number of beads phagocytosed by B2m -/- and B2m +/+ PEMϕs, regardless of particle size ( Figures 3A, B ). However, membrane ruffling and actin remodeling in B2m -/- PEMϕs were phenocopies of those in Ly49Q-YF PEMϕs in membrane regions where phagocytosis occurs; B2m +/+ PEMϕs promptly formed membrane ruffles around beads, whereas B2m -/- PEMϕs did not, although polymerized actin surrounded the beads in both PEMϕs ( Figure 3C ). Although both B2m +/+ and B2m -/- PEMϕs engulfed multiple beads in their cytoplasm, periphagosomal F-actin was lost in B2m +/+ but not in B2m -/- PEMϕs at the indicated time points ( Figures 3D, E ). The frequency of cells showing F-actin-uncoated phagosomes was significantly higher in B2m +/+ PEMϕs than in B2m -/- PEMϕs ( Figure 3F ). Conversely, the frequency of cells showing F-actin-coated phagosomes was significantly higher in B2m -/- PEMϕs than in B2m +/+ PEMϕs ( Figure 3F ). The frequency of hybrid-type cells showing both F-actin-uncoated and F-actin-coated phagosomes was not affected by the presence or absence of β2-microglobulin ( Figure 3F ).
Taken together, these findings suggest that MHC-I is involved in determining the mode of FcγR-mediated phagocytosis and in phagosome destiny. Based on the cis-interaction between Ly49Q and MHC-I, these findings imply that the role of MHC-I in actin remodeling during phagocytosis is exerted via the interaction with Ly49Q.
The Ly49Q ITIM recruits signaling molecules for actin remodeling
Inhibitory NK cell receptors with ITIM interact with MHC-I and are considered to induce tyrosine phosphorylation of ITIM. Phosphorylated ITIM recruits SHP1 and SHP2, which is also the case for the Ly49Q ITIM (13). However, it seemed difficult to explain the complex actin remodeling associated with phagocytosis solely by the function of these protein phosphatases. Therefore, we further exhaustively searched for ITIM-associated molecules using a synthetic peptide corresponding to a phosphorylated ITIM (pITIM) of Ly49Q.
Multiple proteins that selectively associated with pITIM but not with nonphosphorylated ITIM were identified by mass spectrometry (MS) ( Figure 4A ). The direct association between the pITIM and SH2 domains of the identified proteins was confirmed using recombinant proteins in vitro ( Figure 4B ), indicating that Ly49Q has the potential to associate with multiple molecules in addition to protein phosphatases. Among the molecules that bind to pITIM, we focused on the SH2/SH3-containing adaptor proteins Grb2 and CrkL, both of which are involved in actin remodeling by interacting with guanine nucleotide exchange factors (GEFs), such as Sos and C3G, that couple with Rho family members (44–46). CrkL was detected in the Ly49Q immunoprecipitates in an ITIM-dependent manner ( Figure 4C ). Both Grb2 and CrkL colocalized with Ly49Q at chemokine-induced ruffled membranes in RAW264.7 cells ( Figures 4D, E ). Ly49Q-YF also partially colocalized with Grb2, but chemokine-induced membrane ruffling was not observed in RAW264.7 cells expressing Ly49Q-YF ( Figure 4E ). Ly49Q ITIM also has the potential to recruit SHIP1 and SHIP2 to the ruffled region ( Figures 4F, G ). These observations indicated that Ly49Q has the potential to affect actin dynamics by recruiting multiple actin-regulating proteins to its phosphorylated ITIM.
Ly49Q binds sulfatide and modulates retention of cholesterol in the plasma membrane
Ly49Q localizes to lipid rafts and regulates their trafficking (13). Given that Ly49Q can recruit multiple actin remodeling molecules to lipid rafts and that lipid rafts are important in phagocytosis (47), it is important to determine whether or not Ly49Q-mediated actin regulation during phagocytosis is lipid raft-dependent.
To this end, we treated Ly49Q transfectants (7) with methyl-β-cyclodextrin (mβCD) (22) to deplete cholesterol in order to disrupt lipid raft organization. Unexpectedly, treatment with 5 mM mβCD killed WEHI3 Ly49Q-WT cells in a short time ( Figures 5A, B ). WEHI3 Ly49Q-YF cells and mock transfectants were more resistant to this reagent than WEHI3 Ly49Q-WT cells ( Figures 5A, B ). Since cholesterol is required for the formation of the permeability barrier of the plasma membrane and mβCD acts strictly at the surface of the plasma membrane (48), these results suggest that acute cholesterol deprivation with mβCD may have caused leakage of the plasma membrane in WEHI3 Ly49Q-WT cells. These results also suggest that Ly49Q has some effect on cholesterol levels or localization in the plasma membrane.
To elucidate the mechanism underlying Ly49Q-dependent cholesterol regulation, we scrutinized Ly49Q’s primary structure and found two possible cholesterol binding motifs, CRAC and CARC, at lipid membrane boundary regions ( Figure 5C , Supplementary Figure 3A ) (30, 31). These cholesterol binding motifs were also identified in other Ly49 family members, and a typical sphingolipid-binding motif was also observed in some Ly49 family members, such as Ly49B and Ly49H ( Supplementary Figure 3A ).
We then examined the lipid binding ability of Ly49Q using GST-fused Ly49Q proteins ( Figure 5C , Supplementary Figure 3B ) but did not detect any binding of Ly49Q to cholesterol by liposome pull-down assays ( Supplementary Figure 3C ). Further examinations using protein-lipid overlay assays revealed that Ly49Q can bind sulfatide ( Figure 5D ). Ly49Q lacking CRAC (Ly49Q 1-56aa) or with substitution of the charged and hydrophilic amino acids in the CRAC motif (YKK) for AAA (Ly49Q 1-78aa ΔYKK) lost the ability to bind sulfatide ( Figures 5C, D ), indicating that Ly49Q binds sulfatide via the CRAC motif. Notably, WEHI3 cells expressing Ly49Q-ΔYKK were less sensitive to cholesterol depletion than Ly49A-WT ( Figures 5A, E ), indicating that the sulfatide binding ability of Ly49Q is critical for the retention of membrane cholesterol. A strong attractive force mediates the interaction between sulfatide and cholesterol to form a condensed structure in the lipid layer that mimics “lipid raft” domains (49).
Taken together, these observations strongly suggest that Ly49Q can self-organize lipid rafts and regulate intracellular cholesterol distribution by interacting with sulfatides via the CRAC motif.
Ly49Q organized SM/GM1/cholesterol membrane domains in LAMP1-positive vesicles
To confirm the significance of the CRAC motif in Ly49Q-mediated lipid raft organization, we performed an immunohistochemical analysis by combining lipid-binding probes. SM and GM1 are the major constituents of lipid rafts and influence cholesterol distribution (50–52). We used FITC-labeled equinatoxin II (EquII) to detect SM (53) together with Alexa594-conjugated cholera toxin B subunit (CTB) to visualize lipid rafts (54). The distributions of both SM and GM1 differed substantially between WEHI3 Ly49Q-WT and other WEHI3 transfectants cells expressing ITIM-deficient or ΔYKK Ly49 mutants; SM colocalized with GM1 in vesicular compartments in WEHI3 Ly49Q-WT cells but not in any other WEHI3 transfectants ( Figure 6A ). SM in WEHI3 Ly49Q-WT cells was detected as small dots in the plasma membrane and cytosol, mostly together with GM1 ( Figure 6A ). The vesicles in which SM and GM1 colocalized were LAMP1+ vesicles ( Figure 6B ). Notably, in WEHI3 Ly49Q-YF and WEHI3 ΔYKK cells, SM patches were detected at the rear edge of filopodia, and the detachment and recovery of adhesion machinery appeared to have failed ( Figure 6A ); thus, colocalization of SM and GM1 in LAMP1+ granules was rarely detected ( Figures 6A, B ). Given that the ITIM of Ly49Q is needed for lipid raft trafficking (13), these results suggest that Ly49Q uses the CRAC motif to construct lipid rafts and places them in their proper locations via the ITIM.
Notably, WEHI3 cells expressing Ly49Q-YF, Ly49Q-ΔYKK, or control vector (mock) exhibited ectopic actin polymerization around intracellular granules and tips of filopodia, but WEHI Ly49Q-WT cells possessed little polymerized actin at these sites ( Figure 6A ). These results indicated that Ly49Q recruited SM to GM1+LAMP1+ granules and promoted actin depolymerization around these compartments in an ITIM- and CRAC motif-dependent manner. Importantly, the inhibition of acid sphingomyelinase (ASMase) by imipramine (55) resulted in actin polymerization around these granules ( Figure 6C ), strongly suggesting that an SM metabolite, such as ceramide, is involved in the regulation of actin polymerization in these LAMP1+ granules. Ceramide suppresses actin polymerization (56); therefore, Ly49Q-mediated SM compartmentalization in LAMP1+ granules may be involved in lysosomal actin dynamics via the ASMase function.
Ly49Q-dependent membrane lipid arrangement in LAMP1+ granules affects granule behavior
LAMP1+ granules can be involved in phagocytic processes by supplying bulk membrane lipids to ruffling membranes and phagolysosomes via focal exocytosis (57, 58). Given that Mϕs with an impaired Ly49Q function were unable to form ruffling membranes and remodel actin properly, we hypothesized that Ly49Q might affect the behavior of LAMP1+ granules upon stimulation through its ITIM- and CRAC motif-dependent functions.
To test this hypothesis, we used a membrane-permeable mucolipin TRP channel 1 (TRPML1)-specific synthetic agonist, ML-SA1, which induces Ca2+ movement from the lysosome lumen into the cytosol (59). TRPML1 mediates Ca2+-dependent lysosomal trafficking and focal exocytosis, which supplies membrane lipids for phagosome formation (59). When WEHI3 transfectants were treated with ML-SA1, lysosomes in WEHI Ly49Q-WT cells gathered and coalesced into giant aggregates ( Figure 6D ). Such aggregated lysosome structures were hardly detectable in other transfectants of mock or mutant Ly49Q ( Figure 6D ). The frequency of cells showing aggregated lysosomes was significantly higher in WEHI Ly49Q-WT cells than in other transfectants ( Figure 6E ). Considering the function of TRPML, the aggregation of LAMP1+ granules in WEHI Ly49Q-WT cells may mimic the polarized movement of lysosomes and/or lysosome-related organelles (LROs) (59, 60). Although characterization of these aggregated LAMP1+ compartments is necessary, the above observations indicated that Ly49Q allocates SM and GM1 to LAMP1+ granules via its sulfatide-binding ability, which is critical for regulating LAMP1+ granule trafficking.
Sulfatide is needed for phagocytosis with membrane ruffling and phagosome maturation
We finally confirmed the significance of sulfatide in phagocytosis and phagosome maturation using cerebroside sulfotransferase (CST)-null (Cst –/-) mice (61). CST catalyzes the transfer of a sulfonate group from 3′-phosphoadenosine-5′-phosphosulfate (PAPS) to the C3 position of the nonreducing terminal galactose of glycolipid oligosaccharides to produce sulfatides and seminolipids (61, 62). Cst –/- mice therefore lack sulfatides and seminolipids (61). PEMϕs from Cst –/- mice exhibited no defects in the uptake of opsonized beads, irrespective of bead diameter, and exhibited a slight increase in the uptake of 2-µm beads ( Figure 7A ). Membrane ruffling after bead capture was barely detected in Cst -/- PEMϕs, and only cytoplasmic protrusions were observed ( Figure 7B ). Phagosome actin-coats in Cst -/- PEMϕs were preserved after incubation for 60 min ( Figure 7B ), and the actin coats around phagosomes were reduced in Cst +/+ PEMϕs at the same time point ( Figure 7B ).
Similar results were obtained when BM-derived Mϕs (BMMϕs) were used. Approximately half of the Cst +/+ BMMϕs showed actin-uncoated mature phagosomes, while the Cst -/- BMMϕs showed a decreased number of mature phagosomes and an increased number of actin-coated immature phagosomes ( Figure 7C ). These results indicated that sulfatide is needed for phagosome actin remodeling. Actin depolymerization of phagosomes was also ASMase-dependent in the BMMϕs because imipramine treatment of WT BMMϕs increased the ratio of cells possessing actin-coated phagosomes ( Figure 7D ), indicating that not only cell lines but also primary Mϕs use the SM-ceramide-axis to control phagosomal actin.
Discussion
We revealed that an atypical and ancestral NK cell receptor, Ly49Q, confers a particular phagocytic effect on Mϕs and is needed for subsequent actin remodeling in phagosomes ( Figure 7E ). This may be important for phagosome maturation, as Ly49Q-deficient Mϕs showed reduced bactericidal activity against Salmonella infection. During phagocytic processes, Ly49Q regulates actin remodeling at the site of phagocytosis and around phagosomes, probably by interacting with MHC-I in cis. In addition to MHC-I binding, two functionally different Ly49Q motifs, the ITIM and the CRAC motif, play critical roles in phagocytosis; the latter is associated with sulfatide and organizes cholesterol- and SM-rich lipid raft domains, and the former recruits a panel of proteins involved in actin remodeling and places them together with lipid rafts to a proper intracellular site, such as LAMP1+ granules, which are the source of membrane lipids for promptly increasing membrane capacity via focal exocytosis during phagocytosis. When Mϕs engulf larger particles, they require an increased membrane capacity, including ruffled membrane formation, to encapsulate these large particles. Sphingolipids, such as sulfatide and SM, have saturated fatty acids and preferentially self-organize liquid-ordered membrane domains together with cholesterol (63). Ly49Q distributes to liquid-ordered lipid rafts via the CRAC motif and can assemble a panel of signaling molecules to lipid rafts via the ITIM domain.
Given that Ly49Q alters raft distribution in a stimulation-dependent manner (13), Ly49Q bearing both ITIM and CRAC motifs has the benefit of redistributing signaling complexes together with organized membrane lipids depending on inflammatory circumstances. Ly49Q-organized lipid rafts constitute membrane ruffles at the site of phagocytosis, and this membrane domain might subsequently be internalized with prey during phagocytosis. Thus, these membrane domains are thought to be primarily involved in the construction of the early phagosome membrane. In this context, actin in phagosomes and ruffled membranes is differentially regulated by the function of Ly49Q; Ly49Q promotes actin polymerization in membrane ruffles at the site of phagocytosis, while it promotes actin depolymerization at phagosomes. When promoting actin depolymerization, Ly49Q allocates SM to phagosomes, which enables local production of metabolites, such as ceramide, to regulate actin dynamics (64). Our findings also revealed that the allocation of an appropriate membrane lipid species to appropriate organelle membranes is controlled by membrane-spanning proteins and is critical for site-specific regulation of biological processes mediated by lipid metabolites.
Our observations indicate that Ly49Q exerts its functions during phagocytosis by interacting with MHC-I, probably in a cis configuration. Given that MHC-I clusters in the plasma membrane (65, 66) and considering the structural basis of MHC-I-Ly49 family interactions, in which one MHC-I molecule can possess more than one Ly49 binding site, i.e. sites 1 and 2, depending on context (67, 68), it is possible that the constitutive cis-interaction between Ly49Q and MHC-I can form a protein complex that includes multiple MHC-I molecules and Ly49Q homodimers. In addition to such stoichiometric assessments of protein−protein interactions, given that sphingolipid, as a saturated fatty acid, can organize a liquid-ordered domain by clustering (63, 69), cis-interaction between MHC-I and Ly49Q might incubate multivalent clusters of ITIMs within a limited membrane area. This might promote the formation of a membrane region where a panel of ITIM-interacting molecules are in close proximity to facilitate the construction of a functional lipid raft as a signaling platform for efficient and concerted regulation of complex biological processes, such as highly regulated actin remodeling. Given that Ly49Q expression is strongly induced by IFNγ in Mϕs (7), it is plausible that inflammatory stimulation might substantially affect the state of functional membrane domains, which strengthens the phagocytic potential and bactericidal activity of Mϕs.
Ly49Q-dependent organization of lipid rafts in LAMP1+ granules in WEHI3 cells allows for several interesting perspectives. LAMP1+ granules generally include late endosomes, lysosomes, and LROs, including cytotoxic granules and secretory lysosomes (70–72). The type of LAMP1+ granule in WEHI3 cells is currently unidentified; therefore, it is difficult to discuss Ly49Q-organized raft behavior in phagocytosis by superimposing the properties of WEHI3 LAMP1+ granules. However, because WEHI3 cells do not actively perform phagocytosis in the steady state, these vesicles in WEHI3 cells are nonphagosomes and are thus probably late endosomes or a certain type of LRO. Based on this scenario, it is intriguing to consider the source of membrane ruffles in the context of focal exocytosis, which is a mechanism for supplying bulk membrane lipids to the site of phagocytosis (59). We currently hypothesize that Ly49Q also mediates the focal exocytosis of lysosomes/LROs prior to making phagocytic membrane ruffles by organizing lipid raft domains in LAMP1+ granules. Our observation that the forced activation of TRPL channels induced trafficking of LAMP1+ granules in an Ly49Q-dependent manner suggested the possible involvement of Ly49Q in Ca2+-triggered lysosome secretion in a particular context and seems to support the above notion. In this context, it is intriguing to compare the LROs of Mϕs as the source of membrane ruffles with the LROs of NK cells, i.e. cytotoxic granules, both of which underlie focal exocytosis (73–75). It should be emphasized that other Ly49 family members also possess lipid binding motifs at the membrane boundary region. Given that Ly49Q is the ancestral gene of the Ly49 family, it would be interesting to consider the mechanistic similarity between prey capture by Mϕ phagocytosis and conjugation of NK cells with target cells (76).
NK cells also make Rho family-dependent ruffles when they attach to target cells, and impaired membrane ruffling severely decreases their cytotoxic activity (77). It is possible that the function of Ly49Q in ruffle formation may be diverted to other NK cell receptors possessing lipid-interacting motifs. According to this scenario, it is interesting to consider that NK cells probably control at least two different types of secretion machineries during their cytotoxic responses: one to supply bulk membrane lipids to make ruffled membranes, and the other for cytotoxic granule secretion. Lysosomes and lysosome-related organelles are highly heterogeneous compartments (60, 70); therefore, it is possible that different secretory pathways in NK cells may be differentially regulated by cis- and trans-interacting NK cell receptors. Alternatively, using membrane lipids supplied by the release of cytotoxic granules regulated by trans-interacting NK cell receptors, cis-interactable NK cell receptors may mediate ruffled membrane formation, thereby capturing the target. Although further precise investigations are needed to confirm these issues, our findings provide a novel perspective on the function of cis-interacting NK cell receptors.
Our data clearly demonstrate that Ly49Q provides a specialized and functionally important membrane domain in Mϕs through the integrative organization of protein−protein and protein-lipid interactions. There is still much to discover concerning the regulation of membrane architecture, including lipid rafts, as cells perform their various functions. Our results clearly demonstrate that membrane-spanning receptors precisely organize functional and cell type-specific membrane lipid environments. This mechanism may be critical for immune cells to perform their diverse functions.
Materials and methods
Mouse models
C57BL/6 Klra17–/– mice (13) and C57BL/6 Cst -/- mice (61) were described previously. C57BL/6J mice were purchased from CLEA Japan, Inc (Tokyo, Japan). All animal experiments were approved by the Animal Care and Use Committee of the National Center for Global Health and Medicine (NCGM) Research Institute and were conducted according to institutional procedures (No. 20050).
Cells and antibodies
WEHI3 and its transfectants, except for WEHI3 Ly49Q-ΔYKK, were described previously (7, 13). WEHI3 Ly49Q-ΔYKK was established by substitution of tyrosine 71 and lysines 72 and 75 with alanines by polymerase chain reaction (PCR)-based cloning using PrimeSTAR GXL DNA polymerase (TaKaRa Bio Inc., Shiga, Japan) and the following primer set: Ly49Q Y71A K72A K75A, F 5′-CTTCTGGTAATTGTTGCAGTGTTGGTGACAAACATTTTGCAGGCTGCCCAAGAAGCCCATGAACTGCAGGAAAC-3′; Ly49Q WT R, 5′-AAGGACACAGAGGATTCCAAAAGCTATCACAATGAGATGCCAGGGGATAGAGCACTCTTTGTGGCCAGCTTCTC-3′.
PEMϕs were collected from the peritoneal cavity by injecting cold phosphate-buffered saline (PBS) containing 0.05% EDTA. Cells were cultured in RPMI 1640 Complete Medium (Nacalai Tesque Co. Kyoto, Japan) supplemented with 10% (v/v) fetal bovine serum (FBS), 10 mM 2-mercaptoethanol, 2 mM L-glutamine, 1 mM sodium pyruvate, 2 mM nonessential amino acids, 1% penicillin G/streptomycin, and 10 mM HEPES (pH 7.0) in a humidified incubator at 37°C with 5% CO2.
Bone marrow (BM)-derived Mϕs (BMMϕs) were differentiated from BM mononuclear cells in the presence of murine M-CSF (50 ng/mL) as described previously (78). Antibodies against the following proteins were purchased: phosphorylated ERK, ERK, phosphorylated IκBα, IκB, PLCγ2, Csk, Lyn, Shc, CrkL, Grb2, and β-actin from Cell Signaling Technology; LAMP1 (1D4B) from eBioScience; CD18 (M18/2) from BD Pharmingen; H-2Kb from BioLegend; Flag (M2) from Sigma; Acti-stain 670 Phalloidin from Cytoskeleton; Alexa Fluor 488-conjugated and Alexa Fluor 594-conjugated anti-Rabbit IgG, Alexa Fluor 594-conjugated anti-Mouse IgG, Alexa Fluor 594-conjugated anti-Rat IgG, Alexa Flour 594-conjugated phalloidin and Alexa Fluor 594-conjugated Cholera Toxin subunit B from Thermo Fisher Scientific; and Filipin III from Cayman Chemical Co.
Phagocytosis assays
PEMϕs were seeded on fibronectin-coated round glass coverslips (ϕ12 µm; Fisher Scientific Inc. in 24-well plates and cultured for 4 h. In some experiments, PEMϕs were pretreated with imipramine (10 µg/ml) at 37°C and 5% CO2 for 30 min. Polybead® Polystyrene Microspheres (Polyscience Inc.) were coated with mouse IgG (1 mg/ml in PBS) at room temperature for 1 h and added to PEMϕs. Subsequently, the plate was spun to attach beads and further incubated at 37°C and 5% CO2 for the indicated periods. The bead-to-PEMϕs ratio was 1:5 for ϕ2-µm beads or 1:2 for ϕ6-µm beads. Two micrometer diameter beads were chosen in light of the fact that E. coli and yeast (Zymosan) are 2-4 and 3 micrometers, respectively. The larger ϕ6 μm beads were chosen because cellular debris is expected to be larger than E. coli or yeast. The erythrocytes physiologically phagocytosed by macrophages are 7 to 8 μm in size, and because in experimental practice phagocytosis efficiency decreases with bead size greater than ϕ10 μm, ϕ6 μm beads were chosen for quantitative accuracy. Cells were fixed with 4% paraformaldehyde (PFA), and immunohistochemical analyses were performed. When phagocytosed beads were counted, fluorescein isothiocyanate-conjugated microspheres were used, and surface binding was discriminated by staining with Alexa Fluor 594-conjugated anti-mouse IgG without cell permeabilization. For quantification of phagocytosis, 5 to 7 images of random fields were recorded, and the number of phagocytosed beads was counted in at least 30 cells. Phagocyte activity is represented as beads/cell.
S. typhimurium infection in vitro
S. typhimurium strain SH100 WT or ΔInvA was used for in vivo infection experiments (33). PEMϕs were seeded into 24-well plates at a density of 5 × 105 cells/well and infected with mouse serum-opsonized S. typhimurium with a multiplicity of infection of 5. Thirty minutes post infection, the culture medium was replaced with medium containing 100 μg/ml gentamicin for 1 h, and the gentamicin concentration was subsequently reduced to 10 µg/ml. The cells were further incubated for the indicated periods. Subsequently, cells were lysed with 1% Triton X-100 in PBS, and serially diluted cell lysates were plated onto LB agar. The plates were incubated at 37°C overnight, and the resulting colonies were counted. Cell death after S. typhimurium infection was assessed using an LDH-Cytotoxic Test Wako (FUJIFILM Co., Tokyo, Japan) according to the manufacturer’s instructions.
S. typhimurium infection in mice
S. typhimurium strain SH100 WT was used for in vivo infection experiments. S. typhimurium (1 × 105 cfu/mouse) was suspended in 100 µl PBS and intraperitoneally injected. Two days post-infection, the mice were sacrificed, and the spleens were weighed. To determine colony forming unit (CFU) in organs of infected mice, spleens and livers were homogenized using a Multibeads shocker cell disruptor (YASUI KIKAI, Osaka, Japan), and serial dilutions of homogenates were prepared and plated onto LB plates. The plates were incubated at 37°C overnight, and the resulting colonies were counted.
Cytokine quantification
PEMϕs were infected with the S. typhimurium SH100 strain as described above, and their culture supernatants were collected at the indicated time points. IL6 levels in PEMϕ supernatants were measured using the Mouse ELISA Max Kit (BioLegend) according to the manufacturer’s instructions.
Lipid binding assays
The lipid binding ability of Ly49Q was examined using Sphingo Strips (Echelon Biosciences Inc.) according to the manufacturer’s instructions. In brief, Shingo Strip membranes were incubated with GST-tagged Ly49Q proteins or control GST [5 µg/ml in tris-buffered saline (TBS) containing 3% bovine serum albumin (BSA)] at 4°C overnight. After washing with TBS-T to remove unbound GST-tagged proteins, Shingo Strip membranes were further incubated with anti-GST antibody (Santa Cruz Biotechnology, Inc.) and subsequently HRP-conjugated anti-mouse IgG (Jackson Laboratory). HRP was detected with Supersignal West Femto or Supersignal West Pico chemiluminescent substrates with the LAS-3000 detection system (FUJIFILM Co., Tokyo, Japan).
Analyses of Ly49Q-cholesterol interaction using liposomes
Liposomes containing 90% phosphatidyl choline and 10% phosphatidyl serine with or without cholesterol (60%) were prepared as described previously (79). Liposomes were mixed with GST-tagged Ly49Q (5–7 mg/50 ml liposomes) and incubated at room temperature for 15 min. Subsequently, the liposomes were pelleted by centrifugation in a TLS-55 rotor (BECKMAN COULTER Co.) at 20°C for 30 min at 48000 rpm (200000 g). The supernatant (S) containing the free protein that was not bound to liposomes was collected. The liposome pellets (P) containing the cosedimented proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS−PAGE) followed by Coomassie brilliant blue staining or Western blotting using an anti-GST antibody.
Protein expression in Escherichia coli
Plasmids encoding the SH2 domains of the phospho-ITIM-interacting proteins were introduced into BL21 (DE3) Rosetta cells, and protein expression was induced by incubation with 0.2 mM IPTG for 3 h at 30°C. Soluble fractions of BL21 Rosetta cells were prepared and used for peptide pull-down assays. GST-tagged Ly49Q deletion mutant proteins were collected from BL21 Rosetta cell soluble fractions using glutathione-Sepharose 4B columns according to the manufacturer’s instructions (Thermo Fisher Scientific) and eluted with 10 mM reduced glutathione in 50 mM Tris pH 8.0. Purified proteins were dialyzed overnight against PBS before use in lipid binding assays.
Plasmid construction
To express the Glutathione S-Transferase (GST)-tagged Ly49Q mutants in E. coli, DNA corresponding to the mutant proteins indicated was amplified by PCR and cloned and inserted into pGEX4T1 (GE Healthcare Technologies Inc.). To express GST- or His6-tagged fusion proteins in E. coli, DNA corresponding to the SH2 domains of the phospho-ITIM-interacting proteins was amplified by PCR and cloned and inserted into pGEX4T1 or pET19b (Merck Millipore Co.). The expressed SH2 domains were as follows: mouse CrkL (residues 1–110), mouse Lyn (residues 101–250), mouse Shc (residues 451–579), mouse Grb2 (residues 41–190), mouse Csk (residues 50–200), mouse Hck (residues 100–250), mouse Fgr (residues 100–250), and mouse PLCγ2 (residues 501–640, 501–750, and 625–750). Mouse Grb2 and Ly49Q were cloned and inserted into pCAG-HA or pCAGGS-EGFP expression vectors.
Peptide pull-down assays
Peptides corresponding to the tyrosine-phosphorylated ITIM of Ly49Q (CGGMSEQEVTpYSTVRFHK) and to the nonphosphorylated ITIM (CGGMSEQEVTYSTVRFHK) were synthesized by Operon Biotechnologies Inc.) and conjugated to SulfoLink resin according to the manufacturer’s instructions (Thermo Fisher Scientific). Lysates of Raw264.7 cells were prepared with lysis buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 10% glycerol, 150 mM NaCl, 1% NP-40, and protease/phosphatase inhibitors (Thermo Fisher Scientific) and incubated with the peptide-conjugate resins for 1 h at 4°C. The resins were then washed with lysis buffer, and the proteins bound to the resin were separated by SDS−PAGE and visualized by silver staining. Proteins specifically bound to the phosphorylated ITIM peptides were excised and subjected to liquid chromatography-tandem mass spectrometry (LC−MS/MS; APRO Science Inc.).
Immunoprecipitation
Cell lysates of WEHI3 cells were prepared with lysis buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 10% glycerol, 150 mM NaCl, 1% Triton-X100, and protease/phosphatase inhibitors. In some experiments, the cells were subjected to pervanadate treatment prior to preparing the lysates. The obtained cell extracts were incubated with antibody-conjugated agarose beads for 1 h at 4°C, and the precipitated proteins were analyzed by SDS−PAGE and immunoblotting.
Transfection of RAW264.7 cells
RAW264.7 cells were transfected with GFP-tagged Ly49Q-WT or GFP-tagged Ly49Q-YF expression vectors using the Neon transfection system according to the manufacturer’s instructions (Life Technologies Inc.). HEK293T cells were transfected with Myc-tagged SHIP1 or SHIP2 expression vectors using Fugene HD (Roche Inc.).
Time-lapse analyses
PEMϕs were seeded in glass-bottom culture dishes (CELLview™ Cell culture dish; Greiner Bio-One Co.) and cultured overnight. Time-lapse images of PEMϕs were acquired using a BZ-X710 microscope (Keyence, Osaka, Japan) equipped with a CFI60 CFI Plan Apoλ 60× objective (Nikon Co., Tokyo, Japan).
Biochemical experiments
WEHI3 transfectants were lysed in 1% NP-40 lysis buffer (50 mM Tris-HCl [pH 7.5], 1 mM EDTA, 10% glycerol, 150 mM NaCl, 1% NP-40) containing Halt protease inhibitor cocktail and Halt phosphatase inhibitor cocktail EDTA-free (Thermo Fisher Scientific). After extraction by rotation at 4°C for 30 min, cell lysates were collected by centrifugation, and anti-Flag antibody (M2; Sigma) was added. After incubation on ice for 1 h, the cell lysates were further incubated with rabbit anti-mouse IgG and Protein G beads at 4°C with rotation for 1 h. After washing the beads 3 times with lysis buffer, the precipitates were collected in SDS-sample buffer, heated to 95°C for 5 min, and analyzed by Western blotting.
Cholesterol depletion experiments
WEHI3 transfectants in 24-well plates were treated with the indicated concentration of methyl-β-cyclodextrin (Sigma-Aldrich) for the indicated periods. The cells were collected in propidium iodide (PI) (Sigma)-containing FACS buffer (PBS containing 0.1% BSA and 0.5% EDTA) and immediately analyzed by flow cytometry (FACSCalibur; Becton Dickinson and Company Co.). The percentages of PI-positive cells were analyzed by CellQuest (FACSCalibur; Becton Dickinson and Company Co.).
Gene expression analyses
RNA from cells was purified using an RNeasy Mini Kit (QIAGEN Inc., Germany) or ISOGEN (NIPPON GENE Co., Tokyo, Japan) and reverse-transcribed using the LunaScript™ RT SuperMix Kit (New England Biolabs Inc.). SYBR-based quantitative PCR was conducted with the StepOne Plus Real-Time PCR System (Thermo Fisher Scientific) with specific primers for murine IL6 or HPRT (Thermo Fisher Scientific). Gene expression was normalized to HPRT.
Statistical analyses
The statistical significance of differences between obtained values was determined by an analysis of variance, the Mann−Whitney U test or One-way ANOVA using the Prism 6.0 software program (GraphPad Software Inc.). Data are presented as mean ± standard deviation (SD). Differences with a P value <0.05 were considered significant.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The animal study was approved by The Animal Care and Use Committee of the National Center for Global Health and Medicine (NCGM) Research Institute. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
HK: Investigation, Writing – review & editing. TN: Resources, Writing – review & editing. YS: Investigation, Validation, Writing – review & editing. SH: Investigation, Writing – review & editing. SS: Investigation, Writing – review & editing. TH: Methodology, Resources, Writing – review & editing. KM: Investigation, Methodology, Resources, Writing – review & editing. KK: Resources, Writing – review & editing. KT: Investigation, Supervision, Writing – review & editing. NG: Supervision, Writing – review & editing. KH: Methodology, Resources, Writing – review & editing. TT: Investigation, Methodology, Resources, Writing – review & editing. HS: Data curation, Supervision, Writing – review & editing. NT: Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.
Acknowledgments
We thank all department members for helpful discussions, Dr. Y. Handa for technical support, and Dr. Haneda for providing Salmonellae mutant strains. We also thank Dr. Brian Quinn, from Japan Medical Communications (www.japan-mc.co.jp) and Jeremy Allen, PhD, from Edanz Group (https://en-author-services.edanz.com/ac) for editing a draft of this manuscript.
Funding Statement
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (for NT-S, 17H04070, 15H05903, 21H04803), by a grant from the National Center for Global Health and Medicine (for NT-S, 23S001), and by a grant from AMED under Grant Number 223fa727002h0001.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1401294/full#supplementary-material
References
- 1. Jonsson AH, Yokoyama WM. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol. (2009) 101:27–79. doi: 10.1016/S0065-2776(08)01002-X [DOI] [PubMed] [Google Scholar]
- 2. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. (2013) 31:227–58. doi: 10.1146/annurev-immunol-020711-075005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Doucey MA, Scarpellino L, Zimmer J, Guillaume P, Luescher IF, Bron C, et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol. (2004) 5:328–36. doi: 10.1038/ni1043 [DOI] [PubMed] [Google Scholar]
- 4. Arosa FA, Santos SG, Powis SJ. Open conformers: the hidden face of MHC-I molecules. Trends Immunol. (2007) 28:115–23. doi: 10.1016/j.it.2007.01.002 [DOI] [PubMed] [Google Scholar]
- 5. Lanier LL. Natural killer cell receptor signaling. Curr Opin Immunol. (2003) 15:308–14. doi: 10.1016/S0952-7915(03)00039-6 [DOI] [PubMed] [Google Scholar]
- 6. Natarajan K, Dimasi N, Wang J, Margulies DH, Mariuzza RA. MHC class I recognition by Ly49 natural killer cell receptors. Mol Immunol. (2002) 38:1023–7. doi: 10.1016/S0161-5890(02)00031-7 [DOI] [PubMed] [Google Scholar]
- 7. Toyama-Sorimachi N, Tsujimura Y, Maruya M, Onoda A, Kubota T, Koyasu S, et al. Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc Natl Acad Sci U S A. (2004) 101:1016–21. doi: 10.1073/pnas.0305400101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Tai LH, Goulet ML, Belanger S, Troke AD, St-Laurent AG, Mesci A, et al. Recognition of H-2K(b) by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function. Mol Immunol. (2007) 44:2638–46. doi: 10.1016/j.molimm.2006.12.010 [DOI] [PubMed] [Google Scholar]
- 9. Tai LH, Goulet ML, Belanger S, Toyama-Sorimachi N, Fodil-Cornu N, Vidal SM, et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med. (2008) 205:3187–99. doi: 10.1084/jem.20080718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Sasawatari S, Karyu H, Nguyen Tien D, Furuyama-Tanaka K, Toyama-Sorimachi N. The inhibitory NK receptor Ly49Q protects plasmacytoid dendritic cells from pyroptotic cell death. Mol Immunol. (2021) 135:217–25. doi: 10.1016/j.molimm.2021.03.023 [DOI] [PubMed] [Google Scholar]
- 11. Omatsu Y, Iyoda T, Kimura Y, Maki A, Ishimori M, Toyama-Sorimachi N, et al. Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. J Immunol. (2005) 174:6657–62. doi: 10.4049/jimmunol.174.11.6657 [DOI] [PubMed] [Google Scholar]
- 12. Toyama-Sorimachi N, Omatsu Y, Onoda A, Tsujimura Y, Iyoda T, Kikuchi-Maki A, et al. Inhibitory NK receptor Ly49Q is expressed on subsets of dendritic cells in a cellular maturation- and cytokine stimulation-dependent manner. J Immunol. (2005) 174:4621–9. doi: 10.4049/jimmunol.174.8.4621 [DOI] [PubMed] [Google Scholar]
- 13. Sasawatari S, Yoshizaki M, Taya C, Tazawa A, Furuyama-Tanaka K, Yonekawa H, et al. The Ly49Q receptor plays a crucial role in neutrophil polarization and migration by regulating raft trafficking. Immunity. (2010) 32:200–13. doi: 10.1016/j.immuni.2010.01.012 [DOI] [PubMed] [Google Scholar]
- 14. Mass E, Nimmerjahn F, Kierdorf K, Schlitzer A. Tissue-specific macrophages: how they develop and choreograph tissue biology. Nat Rev Immunol. (2023) 23:563–79. doi: 10.1038/s41577-023-00848-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Jain N, Moeller J, Vogel V. Mechanobiology of macrophages: how physical factors coregulate macrophage plasticity and phagocytosis. Annu Rev BioMed Eng. (2019) 21:267–97. doi: 10.1146/annurev-bioeng-062117-121224 [DOI] [PubMed] [Google Scholar]
- 16. Mylvaganam S, Freeman SA, Grinstein S. The cytoskeleton in phagocytosis and macropinocytosis. Curr Biol. (2021) 31:R619–R32. doi: 10.1016/j.cub.2021.01.036 [DOI] [PubMed] [Google Scholar]
- 17. Cannon GJ, Swanson JA. The macrophage capacity for phagocytosis. J Cell Sci. (1992) 101:907–13. doi: 10.1242/jcs.101.4.907 [DOI] [PubMed] [Google Scholar]
- 18. Braun V, Niedergang F. Linking exocytosis and endocytosis during phagocytosis. Biol Cell. (2006) 98:195–201. doi: 10.1042/BC20050021 [DOI] [PubMed] [Google Scholar]
- 19. Levin R, Grinstein S, Schlam D. Phosphoinositides in phagocytosis and macropinocytosis. Biochim Biophys Acta. (2015) 1851:805–23. doi: 10.1016/j.bbalip.2014.09.005 [DOI] [PubMed] [Google Scholar]
- 20. Cox D, Dale BM, Kashiwada M, Helgason CD, Greenberg S. A regulatory role for Src homology 2 domain-containing inositol 5'-phosphatase (SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3 (alpha(M)beta(2); CD11b/CD18). J Exp Med. (2001) 193:61–71. doi: 10.1084/jem.193.1.61 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Bryan AM, You JK, Li G, Kim J, Singh A, Morstein J, et al. Cholesterol and sphingomyelin are critical for Fcgamma receptor-mediated phagocytosis of Cryptococcus neoformans by macrophages. J Biol Chem. (2021) 297:101411. doi: 10.1016/j.jbc.2021.101411 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Sviridov D, Mukhamedova N, Miller YI. Lipid rafts as a therapeutic target. J Lipid Res. (2020) 61:687–95. doi: 10.1194/jlr.TR120000658 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. (1998) 14:111–36. doi: 10.1146/annurev.cellbio.14.1.111 [DOI] [PubMed] [Google Scholar]
- 24. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. (1997) 387:569–72. doi: 10.1038/42408 [DOI] [PubMed] [Google Scholar]
- 25. Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. (2017) 18:361–74. doi: 10.1038/nrm.2017.16 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. (2002) 110:597–603. doi: 10.1172/JCI16390 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Sych T, Gurdap CO, Wedemann L, Sezgin E. How does liquid-liquid phase separation in model membranes reflect cell membrane heterogeneity? Membranes. (2021) 11:323. doi: 10.3390/membranes11050323 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Busto JV, Garcia-Arribas AB, Sot J, Torrecillas A, Gomez-Fernandez JC, Goni FM, et al. Lamellar gel (lbeta) phases of ternary lipid composition containing ceramide and cholesterol. Biophys J. (2014) 106:621–30. doi: 10.1016/j.bpj.2013.12.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Kraft ML. Sphingolipid organization in the plasma membrane and the mechanisms that influence it. Front Cell Dev Biol. (2016) 4:154. doi: 10.3389/fcell.2016.00154 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Di Scala C, Baier CJ, Evans LS, Williamson PTF, Fantini J, Barrantes FJ. Relevance of CARC and CRAC cholesterol-recognition motifs in the nicotinic acetylcholine receptor and other membrane-bound receptors. Curr Top Membr. (2017) 80:3–23. doi: 10.1016/bs.ctm.2017.05.001 [DOI] [PubMed] [Google Scholar]
- 31. Fantini J, Epand RM, Barrantes FJ. Cholesterol-recognition motifs in membrane proteins. Adv Exp Med Biol. (2019) 1135:3–25. doi: 10.1007/978-3-030-14265-0_1 [DOI] [PubMed] [Google Scholar]
- 32. Jongstra-Bilen J, Harrison R, Grinstein S. Fcgamma-receptors induce Mac-1 (CD11b/CD18) mobilization and accumulation in the phagocytic cup for optimal phagocytosis. J Biol Chem. (2003) 278:45720–9. doi: 10.1074/jbc.M303704200 [DOI] [PubMed] [Google Scholar]
- 33. Haneda T, Sugimoto M, Yoshida-Ohta Y, Kodera Y, Oh-Ishi M, Maeda T, et al. Comparative proteomic analysis of Salmonella enterica serovar Typhimurium ppGpp-deficient mutant to identify a novel virulence protein required for intracellular survival in macrophages. BMC Microbiol. (2010) 10:324. doi: 10.1186/1471-2180-10-324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Galan JE, Curtiss R, 3rd. Distribution of the invA, -B, -C, and -D genes of Salmonella typhimurium among other Salmonella serovars: invA mutants of Salmonella typhi are deficient for entry into mammalian cells. Infect Immun. (1991) 59:2901–8. doi: 10.1128/iai.59.9.2901-2908.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Hobbie S, Chen LM, Davis RJ, Galan JE. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol. (1997) 159:5550–9. doi: 10.4049/jimmunol.159.11.5550 [DOI] [PubMed] [Google Scholar]
- 36. Zhang S, Adams LG, Nunes J, Khare S, Tsolis RM, Baumler AJ. Secreted effector proteins of Salmonella enterica serotype typhimurium elicit host-specific chemokine profiles in animal models of typhoid fever and enterocolitis. Infect Immun. (2003) 71:4795–803. doi: 10.1128/IAI.71.8.4795-4803.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Chang SJ, Song J, Galan JE. Receptor-mediated sorting of typhoid toxin during its export from salmonella typhi-infected cells. Cell Host Microbe. (2016) 20:682–9. doi: 10.1016/j.chom.2016.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Stow JL, Condon ND. The cell surface environment for pathogen recognition and entry. Clin Transl Immunol. (2016) 5:e71. doi: 10.1038/cti.2016.15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Swanson JA. Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol. (2008) 9:639–49. doi: 10.1038/nrm2447 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Kinchen JM, Ravichandran KS. Phagosome maturation: going through the acid test. Nat Rev Mol Cell Biol. (2008) 9:781–95. doi: 10.1038/nrm2515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Nguyen JA, Yates RM. Better together: current insights into phagosome-lysosome fusion. Front Immunol. (2021) 12:636078. doi: 10.3389/fimmu.2021.636078 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Poirier MB, Fiorino C, Rajasekar TK, Harrison RE. F-actin flashes on phagosomes mechanically deform contents for efficient digestion in macrophages. J Cell Sci. (2020) 133:jcs239384. doi: 10.1242/jcs.239384 [DOI] [PubMed] [Google Scholar]
- 43. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. (1990) 248:1227–30. doi: 10.1126/science.2112266 [DOI] [PubMed] [Google Scholar]
- 44. Carlier MF, Nioche P, Broutin-L'Hermite I, Boujemaa R, Le Clainche C, Egile C, et al. GRB2 links signaling to actin assembly by enhancing interaction of neural Wiskott-Aldrich syndrome protein (N-WASp) with actin-related protein (ARP2/3) complex. J Biol Chem. (2000) 275:21946–52. doi: 10.1074/jbc.M000687200 [DOI] [PubMed] [Google Scholar]
- 45. Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell. (2002) 10:1269–81. doi: 10.1016/S1097-2765(02)00728-1 [DOI] [PubMed] [Google Scholar]
- 46. Ichiba T, Kuraishi Y, Sakai O, Nagata S, Groffen J, Kurata T, et al. Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2. J Biol Chem. (1997) 272:22215–20. doi: 10.1074/jbc.272.35.22215 [DOI] [PubMed] [Google Scholar]
- 47. Manes S, del Real G, Martinez AC. Pathogens: raft hijackers. Nat Rev Immunol. (2003) 3:557–68. doi: 10.1038/nri1129 [DOI] [PubMed] [Google Scholar]
- 48. Mahammad S, Parmryd I. Cholesterol depletion using methyl-beta-cyclodextrin. Methods Mol Biol. (2015) 1232:91–102. [DOI] [PubMed] [Google Scholar]
- 49. Hao C, Sun R, Zhang J, Chang Y, Niu C. Behavior of sulfatide/cholesterol mixed monolayers at the air/water interface. Colloids Surf B Biointerf. (2009) 69:201–6. doi: 10.1016/j.colsurfb.2008.11.013 [DOI] [PubMed] [Google Scholar]
- 50. Bieberich E. Sphingolipids and lipid rafts: Novel concepts and methods of analysis. Chem Phys Lipids. (2018) 216:114–31. doi: 10.1016/j.chemphyslip.2018.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Slotte JP. Sphingomyelin-cholesterol interactions in biological and model membranes. Chem Phys Lipids. (1999) 102:13–27. doi: 10.1016/S0009-3084(99)00071-7 [DOI] [PubMed] [Google Scholar]
- 52. Silva LC, Futerman AH, Prieto M. Lipid raft composition modulates sphingomyelinase activity and ceramide-induced membrane physical alterations. Biophys J. (2009) 96:3210–22. doi: 10.1016/j.bpj.2008.12.3923 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Mori T, Niki T, Uchida Y, Mukai K, Makino A, Kishimoto T, et al. A novel non-toxic sphingomyelin biosensor, equinatoxin-II elucidated the localization and dynamics in cell membranes. bioRxiv. (2023). doi: 10.1101/2023.11.10.566659 [DOI] [Google Scholar]
- 54. Schon A, Freire E. Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry. (1989) 28:5019–24. doi: 10.1021/bi00438a017 [DOI] [PubMed] [Google Scholar]
- 55. Kornhuber J, Tripal P, Reichel M, Muhle C, Rhein C, Muehlbacher M, et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. (2010) 26:9–20. doi: 10.1159/000315101 [DOI] [PubMed] [Google Scholar]
- 56. Singh RK, Haka AS, Brumfield A, Grosheva I, Bhardwaj P, Chin HF, et al. Ceramide activation of RhoA/Rho kinase impairs actin polymerization during aggregated LDL catabolism. J Lipid Res. (2017) 58:1977–87. doi: 10.1194/jlr.M076398 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Bajno L, Peng XR, Schreiber AD, Moore HP, Trimble WS, Grinstein S. Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation. J Cell Biol. (2000) 149:697–706. doi: 10.1083/jcb.149.3.697 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Cox D, Lee DJ, Dale BM, Calafat J, Greenberg S. A Rab11-containing rapidly recycling compartment in macrophages that promotes phagocytosis. Proc Natl Acad Sci U S A. (2000) 97:680–5. doi: 10.1073/pnas.97.2.680 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Samie M, Wang X, Zhang X, Goschka A, Li X, Cheng X, et al. A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev Cell. (2013) 26:511–24. doi: 10.1016/j.devcel.2013.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Bowman SL, Bi-Karchin J, Le L, Marks MS. The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases. Traffic. (2019) 20:404–35. doi: 10.1111/tra.12646 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, et al. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci U S A. (2002) 99:4227–32. doi: 10.1073/pnas.032068299 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Honke K. Biosynthesis and biological function of sulfoglycolipids. Proc Jpn Acad Ser B Phys Biol Sci. (2013) 89:129–38. doi: 10.2183/pjab.89.129 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Simons K, Sampaio JL. Membrane organization and lipid rafts. Cold Spring Harb Perspect Biol. (2011) 3:a004697. doi: 10.1101/cshperspect.a004697 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Zeidan YH, Jenkins RW, Hannun YA. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. J Cell Biol. (2008) 181:335–50. doi: 10.1083/jcb.200705060 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Matko J, Bushkin Y, Wei T, Edidin M. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J Immunol. (1994) 152:3353–60. doi: 10.4049/jimmunol.152.7.3353 [DOI] [PubMed] [Google Scholar]
- 66. Bene L, Balazs M, Matko J, Most J, Dierich MP, Szollosi J, et al. Lateral organization of the ICAM-1 molecule at the surface of human lymphoblasts: a possible model for its co-distribution with the IL-2 receptor, class I and class II HLA molecules. Eur J Immunol. (1994) 24:2115–23. doi: 10.1002/eji.1830240928 [DOI] [PubMed] [Google Scholar]
- 67. Dam J, Guan R, Natarajan K, Dimasi N, Chlewicki LK, Kranz DM, et al. Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol. (2003) 4:1213–22. doi: 10.1038/ni1006 [DOI] [PubMed] [Google Scholar]
- 68. Sawicki MW, Dimasi N, Natarajan K, Wang J, Margulies DH, Mariuzza RA. Structural basis of MHC class I recognition by natural killer cell receptors. Immunol Rev. (2001) 181:52–65. doi: 10.1034/j.1600-065X.2001.1810104.x [DOI] [PubMed] [Google Scholar]
- 69. Kusumi A, Fujiwara TK, Tsunoyama TA, Kasai RS, Liu AA, Hirosawa KM, et al. Defining raft domains in the plasma membrane. Traffic. (2020) 21:106–37. doi: 10.1111/tra.12718 [DOI] [PubMed] [Google Scholar]
- 70. Raposo G, Fevrier B, Stoorvogel W, Marks MS. Lysosome-related organelles: a view from immunity and pigmentation. Cell Struct Funct. (2002) 27:443–56. doi: 10.1247/csf.27.443 [DOI] [PubMed] [Google Scholar]
- 71. Cheng XT, Xie YX, Zhou B, Huang N, Farfel-Becker T, Sheng ZH. Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons. J Cell Biol. (2018) 217:3127–39. doi: 10.1083/jcb.201711083 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. (2009) 10:623–35. doi: 10.1038/nrm2745 [DOI] [PubMed] [Google Scholar]
- 73. de Saint Basile G, Menasche G, Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol. (2010) 10:568–79. doi: 10.1038/nri2803 [DOI] [PubMed] [Google Scholar]
- 74. Topham NJ, Hewitt EW. Natural killer cell cytotoxicity: how do they pull the trigger? Immunology. (2009) 128:7–15. doi: 10.1111/j.1365-2567.2009.03123.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Griffiths GM, Tsun A, Stinchcombe JC. The immunological synapse: a focal point for endocytosis and exocytosis. J Cell Biol. (2010) 189:399–406. doi: 10.1083/jcb.201002027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Benninger RK, Vanherberghen B, Young S, Taner SB, Culley FJ, Schnyder T, et al. Live cell linear dichroism imaging reveals extensive membrane ruffling within the docking structure of natural killer cell immune synapses. Biophys J. (2009) 96:L13–5. doi: 10.1016/j.bpj.2008.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Billadeau DD, Brumbaugh KM, Dick CJ, Schoon RA, Bustelo XR, Leibson PJ. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J Exp Med. (1998) 188:549–59. doi: 10.1084/jem.188.3.549 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Yoshizaki M, Tazawa A, Kasumi E, Sasawatari S, Itoh K, Dohi T, et al. Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q. Blood. (2009) 114:1518–27. doi: 10.1182/blood-2008-12-192344 [DOI] [PubMed] [Google Scholar]
- 79. Kawasaki A, Sakai A, Nakanishi H, Hasegawa J, Taguchi T, Sasaki J, et al. PI4P/PS countertransport by ORP10 at ER-endosome membrane contact sites regulates endosome fission. J Cell Biol. (2022) 221:e202103141. doi: 10.1083/jcb.202103141 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.